Pacific Biometrics Schedules Third Quarter Conference Call for Monday, May 18, 2009

SEATTLE, WA--(Marketwire - May 11, 2009) - Pacific Biometrics, Inc. (OTCBB: PBME), which provides specialty reference laboratory services to support pharmaceutical and laboratory diagnostic manufacturers in the conduct of human clinical research, today announced that it has scheduled an investor conference call for 11:00 a.m. EDT on Monday, May 18, 2009 to review the Company’s operating results for the third quarter and first nine months of FY2009. The Company will report its operating results for the quarter and nine months ended March 31, 2009 before the market opens on May 18, 2009.

Shareholders and other interested parties may participate in the conference call by dialing 800-860-2442 (international/local participants dial 412-858-4600) and requesting participation in the “Pacific Biometrics, Inc. Conference Call” a few minutes before 11:00 a.m. EDT on May 18, 2009. A replay of the conference call will be available one hour after the call through May 27, 2009 at 9:00 a.m. EDT by dialing 877-344-7529 (international/local participants dial 412-317-0088) and entering the Conference ID 430456.

About Pacific Biometrics, Inc. (PBI)

Established in 1989, PBI provides specialized central laboratory and contract research services to support pharmaceutical and diagnostic manufacturers conducting human clinical trial research, including expert services in the areas of cardiovascular disease, diabetes, osteoporosis, arthritis, and nutrition. The PBI laboratory is accredited by the College of American Pathologists, New York State, and the Lipid Standardization Program. PBI’s clients include many of the world’s largest pharmaceutical, biotech, and diagnostic companies.

Pacific Biomarkers, a wholly owned subsidiary of PBI, focuses specifically on the emerging field of biomarker assay development and testing. Services include validating and performing ligand-binding assays for novel clinical biomarkers, immunogenicity testing, and multiplex testing.

PBI is headquartered in Seattle, Washington, and its common stock trades on the OTC Bulletin Board under the symbol “PBME.” For more information about PBI, visit the company’s web site at www.pacbio.com.